Healthtech Investors & VC Firms in Asia-Pacific
838 firms in this list, with a median first check of $600K. 163 of them lead rounds. Generated from verified public data and updated continuously.
The Yield Lab
SingaporePre-Seed–Series A$48K – $12M
2 people
Rebright Partners
TokyoPre-Seed–Series A
10 people
Hongtai Capital Holdings
BeijingSeed–Late Stage
Seiho Investment Works
KyotoPre-Seed–Growth$67K – $670K
7 people
Delight Ventures
TokyoPre-Seed–Growth$429K – $312M
Ellerston Capital
SydneySeries A–Late Stage
18 people
Cherubic Ventures
Grand CaymanPre-Seed–Series A$220K – $27M
8 people
Femto Partners
TokyoPre-Seed–Growth$2M – $6M
7 people
Tin Alley Ventures
MelbournePre-Seed–Late Stage
14 people
Industrial Technology Investment Corporation
TaipeiSeed–Late Stage$1.9M – $227M
Lifetime Ventures
OkinawaPre-Seed–Growth
5 people
ICCP Venture Partners
Makati CitySeed–Late Stage
13 people
Aroa Venture Partners
GurgaonPre-Seed–Series C$100K – $500K
15 people
Japan startup support Association
OsakaPre-Seed–Growth
1 person
T-Hub
HyderabadPre-Seed–Series A
13 people
AI Angel Club
SeoulPre-Seed–Series A$74K – $4.8M
Teja Ventures
SingaporePre-Seed–Series A$1M – $20M
12 people
ANDHealth ACTIVATE
MelbournePre-Seed–Series A
17 people
Fundamentum
GurugramSeries A–Growth$10M – $25M
4 people
TBT
SeoulPre-Seed–Late Stage
CVC Asia Pacific (Japan) Kabushiki Kaisha
TokyoSeries B–Late Stage
11 people
Breakthrough Victoria
MelbournePre-Seed–Late Stage
7 people
DCP Capital
Camana Bay, Grand CaymanGrowth–Late Stage
8 people
Hundreds Capital
BeijingSeed–Late Stage
3 people
Related lists
Investors & VC Firms in North America (13013)Investors & VC Firms in United States (12149)Investors & VC Firms in Europe (5511)Crypto & Web3 Investors & VC Firms (4820)Investors & VC Firms in Global (4182)SaaS Investors & VC Firms (3878)AI & Machine Learning Investors & VC Firms (3817)Fintech Investors & VC Firms (3738)Investors & VC Firms in Asia-Pacific (3570)Healthtech Investors & VC Firms (3445)
Data sourced from public filings and firms' own websites — see our methodology.



































































